SOPH Stock Analysis: Buy, Sell, or Hold?
SOPH - SOPHiA GENETICS SA Ordinary Shares
$4.78
-0.16 (-3.24%)
▼
5d:
-5.91%
30d:
-9.64%
90d:
+13.14%
HOLD
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When SOPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SOPH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SOPH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SOPH is currently trading at $4.78, which is considered slightly low relative to its 30-day fair value range of $4.73 to $5.19.
Technical Outlook: Technically, SOPH is showing sideways momentum. Immediate support is located at $4.55, while resistance sits at $5.20. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: SOPH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.00 (+67.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SOPH is showing sideways momentum. Immediate support is located at $4.55, while resistance sits at $5.20. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: SOPH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.00 (+67.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$4.73 -
$5.19
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 67.4% below Wall St target ($8.00)
- CAUTION: 5-day price weakness (-5.9%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$4.73 -
$5.19
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$4.55
Resistance Level
$5.20
Current Trend
Sideways
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.54
Wall Street Target
$8.00
(+67.4%)
Revenue Growth (YoY)
22.0%
Profit Margin
-99.7%
Share & Embed Analysis
Last updated: June 03, 2026 7:48 PM ET
Data refreshes hourly during market hours. Next update: 8:48 PM
Data refreshes hourly during market hours. Next update: 8:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SOPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Puylaert
SELL
33 shares
2026-04-20
Manuela Valente
SELL
380 shares
2026-04-20
Philippe Menu
SELL
608 shares
2026-04-20
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$263 | 62 BUY |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 50 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 59 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$15 | 55 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$113 | 60 BUY |
